Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Extension Study of EFC12492, R727-CL-1112, EFC12732 and LTS11717 Studies to Assess the Long-Term Safety and Efficacy of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia

NCT01954394 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01954394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01954394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Extension Study of EFC12492, R727-CL-1112, EFC12732 and LTS11717 Studies to Assess the Long-Term Safety and Efficacy of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
December 17, 2013
Completion date
June 30, 2017
Enrollment
986 (actual)
Sites
177

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia